Analysis ID |
212 |
Analysis location |
“GENESIS” Centre for Medical Genetics |
Diagnosed illness |
Breast cancer, genetic predisposition - panel I (multi-gene test) |
OMIM |
#114480 |
Clinical information |
Breast cancer, genetic predisposition - panel I (multi-gene test). Tested mutations increase the risk of developing breast cancer. |
Type of analysis |
Molecular |
Type of biological material |
5 ml of peripheral blood collected in an ETDA tube; DNA sample |
Analyzed genes |
BRCA1; BRCA2; CHEK2; CYP1B1; NOD2 (3020insC) |
Analysis description |
Analysis consists of a testing for the common mutations in BRCA1, BRCA2, CHEK2, CYP1B1, and NOD2 genes. |
Analysis indication |
Familial aggregation of breast cancer |
Analysis time |
1-2 weeks |
Refund |
No |
CGM laboratory name |
Laboratory for Molecular Genetics and Oncology |